文献速递胸部肿瘤

年龄增长对I期非小细胞肺癌患者病因特异性死亡与并发症的影响:竞争风险分析

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
PubMed 文献 · J Clin Oncol · 2016-10-31

本研究对2000至2011年间在本院接受根治性切除的2186例病理I期非小细胞肺癌患者进行竞争风险分析,评估年龄对肺癌特异性死亡与非癌特异性死亡及严重并发症的影响。结果显示随年龄增长,非癌特异性死亡累积发生率升高,且在≥65岁患者术后2.5年内非癌特异性死亡高于肺癌特异性死亡;低ppo DLCO是严重并发症、1年死亡和非癌特异性死亡的独立预测因素,低ppo FEV1是肺癌特异性死亡的独立预测因素。

要点

  • 在<65岁、65-74岁、≥75岁患者中,5年肺癌特异性死亡累积发生率分别为7.5%、10.7%、13.2%,总体为10.4%。
  • 在<65岁、65-74岁、≥75岁患者中,5年非癌特异性死亡累积发生率分别为1.8%、4.9%、9.0%,总体为5.3%。
  • ≥65岁患者术后2.5年内非癌特异性死亡累积发生率高于肺癌特异性死亡,且≥75岁患者早期非癌特异性死亡高于65-74岁患者。

核心结论

  • 在接受根治性切除的I期非小细胞肺癌患者中,非癌特异性死亡是显著的竞争事件,其影响随年龄增长而增加。

研究设计与样本

  • 竞争风险分析,纳入2000至2011年间在本院接受根治性切除的连续5371例原发性肺癌患者中的2186例病理I期非小细胞肺癌患者。
  • 分析纳入所有已知影响结局的术前临床变量,包括Charlson合并症指数、预测术后一氧化碳弥散量和预测术后第1秒用力呼气容积。

主要发现

  • 2186例患者中1532例(70.1%)≥65岁,其中638例(29.2%)≥75岁。
  • 在<65岁、65-74岁、≥75岁患者中,5年肺癌特异性死亡累积发生率分别为7.5%、10.7%、13.2%,总体为10.4%;非癌特异性死亡累积发生率分别为1.8%、4.9%、9.0%,总体为5.3%。
  • 在≥65岁患者中,术后2.5年内非癌特异性死亡累积发生率高于肺癌特异性死亡累积发生率;≥75岁患者较65-74岁患者早期非癌特异性死亡更高。
  • 多因素分析显示,低预测术后一氧化碳弥散量是严重并发症(P < .001)、1年死亡(P < .001)和非癌特异性死亡(P < .001)的独立预测因素;低预测术后第1秒用力呼气容积是肺癌特异性死亡的独立预测因素(P = .002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose To perform competing risks analysis and determine short- and long-term cancer- and noncancer-specific mortality and morbidity in patients who had undergone resection for stage I non-small-cell lung cancer (NSCLC). Patients and Methods Of 5,371 consecutive patients who had undergone curative-intent resection of primary lung cancer at our institution (2000 to 2011), 2,186 with pathologic stage I NSCLC were included in the analysis. All preoperative clinical variables known to affect outcomes were included in the analysis, specifically, Charlson comorbidity index, predicted postoperative (ppo) diffusing capacity of the lung for carbon monoxide, and ppo forced expiratory volume in 1 second. Cause-specific mortality analysis was performed with competing risks analysis. Results Of 2,186 patients, 1,532 (70.1%) were ≥ 65 years of age, including 638 (29.2%) ≥ 75 years of age. In patients < 65, 65 to 74, and ≥ 75 years of age, 5-year lung cancer-specific cumulative incidence of death (CID) was 7.5%, 10.7%, and 13.2%, respectively (overall, 10.4%); noncancer-specific CID was 1.8%, 4.9%, and 9.0%, respectively (overall, 5.3%). In patients ≥ 65 years of age, for up to 2.5 years after resection, noncancer-specific CID was higher than lung cancer-specific CID; the higher noncancer-specific, early-phase mortality was enhanced in patients ≥ 75 years of age than in those 65 to 74 years of age. Multivariable analysis showed that low ppo diffusing capacity of lung for carbon monoxide was an independent predictor of severe morbidity ( P < .001), 1-year mortality ( P < .001), and noncancer-specific mortality ( P < .001), whereas low ppo forced expiratory volume in 1 second was an independent predictor of lung cancer-specific mortality ( P = .002). Conclusion In patients who undergo curative-intent resection of stage I NSCLC, noncancer-specific mortality is a significant competing event, with an increasing impact as patient age increases.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Eguchi T, Bains S, Lee MC, et al. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis. J Clin Oncol. 2016. PMID: 28095268. doi:10.1200/JCO.2016.69.0834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。